Reference (Jun-21-A4)

biotalkm

June 20, 2021159 views0

[1] Gene therapy of Parkinson’s disease using adeno-associated virus (AAV) vectors (Ozawa K, et al. J Neural Transm Suppl. 2000) (accessed on 4^th May 2021).

[2] Parkinson’s Disease: Gene Therapies (Philippe G. Coune, Bernard L. Schneider, and Patrick Aebischer)

[3] AAV-mediated and pharmacological induction of Hsp70 expression stimulates survival of retinal ganglion cells following axonal injury (Jacky MK Kwong,1 Lei Gu,1 et al., Nov 2014).

[4] The Role of Heat Shock Proteins during Neurodegeneration in Alzheimer’s, Parkinson’s and Huntington’s Disease (Andreas Wyttenbach and André Patrick Arrigo).

[5] Intracranial Injection of Adeno-associated Viral Vectors (Rebecca L. Lowery and Ania K. Majewska)

[6] Stoker TB, Barker RA. Recent developments in the treatment of Parkinson’s Disease. F1000Res. 2020 Jul 31;9:F1000 Faculty Rev-862. doi: 10.12688/f1000research.25634.1. PMID: 32789002; PMCID: PMC7400683.